Effects of OPC-21268, a vasopressin V1-receptor antagonist, on expression of growth factors from glomeruli in spontaneously hypertensive rats

Regulatory Peptides

Volumn 72, Issue 2-3, 1997, Pages 87-95

  Otsuka, Fumio ^a   Ogura, Toshio ^b   Yamauchi, Takayoshi ^a   Oishi, Tetsuya ^a   Hashimoto, Masami ^a   Mimura, Yukari ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Glomerulus; Platelet derived growth factor (PDGF) B chain; Proliferating cell nuclear antigen (PCNA); Spontaneously hypertensive rat (SHR); V1 receptor antagonist; Vasopressin

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; CYCLINE; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BODY WEIGHT; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULUS; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALT LOADING; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ACETYLGLUCOSAMINIDASE; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; GROWTH SUBSTANCES; HEART RATE; HYPERTENSION; KIDNEY GLOMERULUS; ORGAN SIZE; PIPERIDINES; PLATELET-DERIVED GROWTH FACTOR; POLYMERASE CHAIN REACTION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEINURIA; QUINOLONES; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RECEPTORS, VASOPRESSIN; RNA, MESSENGER; SODIUM; TRANSFORMING GROWTH FACTOR BETA; URINE;

ANIMALIA; GLOMERULUS;

EID: 0031592870     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01041-0     Document Type: Article

References (42)

1. Hostetter T.H., Olson J.L., Rennke H.G., Venkatachalam M.A., Brenner B.M. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol. 241:1981;F85-F93.
2. Brenner B.M. Nephron adaptation to renal injury or ablation. Am J Physiol. 249:1985;F324-F337.
3. Ishikawa S., Schrier R.W. Vascular effects of arginine vasopressin, angiotensin II and norepinephrine in adrenal insufficiency. Am J Physiol. 246:1984;H104-H113.
4. Schwelk W.A., Katuzic Z.S., Vanhoutte P.M. Constructions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension. 13:1989;859-864.
5. Omiya T., Yamauchi T., Ogura T., Asanuma M., Ota Z. Angiotensin II induces in vivo c-fos expression from rat renal cortex and medulla. Renal Physiol Biochem. 18:1995;81-88.
6. Yamauchi T., Ogura T., Oishi T., Omiya T., Ota Z. The angiotensin I-converting enzyme inhibitor, cilazapril inhibits the platelet derived growth factor B chain expression in glomeruli of spontaneously hypertensive rats. Renal Physiol Biochem. 18:1995;237-245.
7. Oishi T., Ogura T., Yamauchi T., Harada K., Ota Z. Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats. Reg Pep. 62:1996;89-95.
8. Geisterfer A.A.T., Owens G.K. Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells. Hypertension. 14:1989;413-420.
9. Wolthuis A., Boes A., Rodemann H.P., Grond F. Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells. Kidney Int. 41:1992;124-131.
10. Yamamura Y., Ogawa H., Chihara T., Kondo K., Onogawa T., Nakamura S., Mori T., Tominaga M., Yabuuchi Y. OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist. Science. 252:1991;572-574.
11. Collins T., Ginsburg D., Boss J.M., Orkin S.H., Pober J.S. Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature. 316:1985;748-750.
12. Deynck R., Jarrett J.A., Chen E.Y., Eaton D.H., Bell J.R., Assoian R.K., Roberts A.B., Sporn M.B., Goeddel D.V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-705.
13. Reiss K., Meggs L.G., Li P., Olivetti G., Capasso J.M., Anversa P. Upregulation of IGF1, IGF1-receptor, and late growth related genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol. 158:1994;160-168.
14. Raji L., Azar S., Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 26:1984;137-143.
15. Spiro R.G. Studies on the renal glomerular basement membrane: Preparation and chemical composition. J Biol Chem. 242:1967;1915-1922.
16. Yamauchi T., Ogura T., Oishi T., Harada K., Hashimoto M., Mimura Y., Asano N., Ota Z., Kageyama J. Enhanced pressor response in spontaneously hypertensive rats induced stimulation of vasopressin-V1 receptors. Acta Med Okayama. 49:1995;53-59.
17. Mimura Y., Ogura T., Yamauchi T., Otsuka F., Oishi T., Harada K., Hashimoto M., Ota Z. Effect of vasopressin Vl- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats. Acta Med Okayama. 49:1995;187-194.
18. Hosoya M., Ogura T., Watanabe H., Ota Z., Kageyama J. Autoradiographic localization and age-related changes in vasopressin receptors in spontaneously hypertensive rats. Nephron. 72:1996;281-287.
19. Mimura Y., Ogura T., Kataoka H., Oishi T., Asano N., Kishida M., Yamauchi T., Ogawa N., Makino H. Alteration of renal V1 and V2 receptors in spontaneously hypertensive rats and DOCA-salt hypertensive rats using computerized quantification for macro-autoradiography. Res Commun Mol Pathol Pharmacol. 95:1997;43-56.
20. Mimura Y., Ogura T., Hayakawa N., Otsuka F., Hashimoto M., Yamauchi T., Makino H., Ogawa N. In vitro macro- and micro-autographic localization of V1 and V2 receptors in the rat kidney using OPC-21268 and OPC-31260. Nephron. 76:1997;331-336.
21. Burrel L.M., Phillips P.A., Stephenson J., Risvanis J., Rolls K.A., Johnston C.I. Treatment of mineralocorticoid hypertension with an orally active vasopressin V1 receptor antagonist. Hypertension. 23:1994;737-743.
22. Crofton J.T., Ota M., Share L. Role of vasopressin, the renin-angiotensin system and sex in Dahl salt-sensitive hypertension. J Hypert. 11:1993;1031-1038.
23. Yamada Y., Yamamura Y., Chihara T., Onogawa T., Nakamura S., Yamashita T., Mori T., Tominaga M., Yabuuchi Y. OPC-21268, a vasopressin Vl antagonist, produces hypotension in spontaneously hypertensive rats. Hypertension. 23:1994;200-204.
24. Hofbauer K.G., Mah S.C., Baum H.P., Haenni H., Wood J.M., Kraetz J. Endocrine control of salt and water excretion: the role of vasopressin in DOCA-salt hypertension. J Cardiovasc Pharmacol. 6:1984;S184-191.
25. Shultz P.J., Dicorleto P.E., Silver B.J., Abboud H.E. Mesangial cells express PDGF mRNA and proliferate in response to PDGF. Am J Physiol. 255:1988;F674-F684.
26. Abboud H.E. Platelet-derived growth factor and mesangial cells. Kidney Int. 41:1992;581-583.
27. Floege J., Topley N., Hoppe J., Barrett T.B., Resch K. Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: Modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol. 86:1991;334-341.
28. Sporn M.B., Roberts A.B., Wakefield L.M., Assoian R.K. Transforming growth factor-β: Biological function and chemical structure. Science. 233:1986;532-534.
29. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roch N.S., Wakefield L.M., Heine U.I., Liotta L.A., Falanga V., Kehrl J.H., Fauci A.S. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA. 83:1986;4167-4171.
30. Morales T.I., Roberts A.B. Transforming growth factor β regulates the mechanism of proteoglycans in bovine cartilage organ cultures. J Biol Chem. 263:1988;12828-12831.
31. Edwards D.R., Murphy G., Reynolds J.J., Whitham S.E., Docherty A.J.P., Angel P., Heath J.K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1987;1899-1904.
32. Laiho M., Saksela O., Keski-Oja J. Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J Biol Chem. 262:1987;17467-17474.
33. Matsumoto K., Moriuchi T., Koji T., Nakane P.K. Molecular cloning of cDNA coding for rat proliferating cell nuclear antigen (PCNA/cyclin). EMBO J. 6:1987;637-642.
34. Takasaki Y., Deng J.S., Tan E.M. A nuclear antigen associated with cell proliferation and blast formation. Its distribution in synchronized cells. J Exp Med. 154:1981;1899-1909.
35. VanDierendonck J.M., Wijsman J.H., Keijzer R., Van de Velde C.J.H., Comelisse C.J. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. Am J Pathol. 138:1991;1165-1172.
36. Almendral J.M., Huebsch D., Blundell P.A., MacDonald-Bravo H., Bravo R. Cloning and sequence of the human nuclear protein cyclin. Homology with DNA-binding proteins. Proc Natl Acad Sci USA. 84:1987;1575-1579.
37. Jaskulski D., Gatti G., Travali S., Calabretta B., Baserga R. Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J Biol Chem. 263:1988;10175-10179.
38. Ottavio L., Chang C.D., Rizzo M.G., Travali S., Casadevall C., Baserga R. Importance of introns in the growth regulation of the proliferating cell nuclear antigen gene. Mol Cell Biol. 10:1990;303-309.
39. Ausiello D.A., Kreisberg J.I., Roy C., Karnovsky M.J. Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J Clin Invest. 65:1980;754-760.
40. Kreisberg J.I., Venkatschalam M.A. Vasoactive agents affect mesangial cell adhesion. Am J Physiol. 251:1986;C505-C511.
41. Tolins J.P., Raij L. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury. Hypertension. 16:1990;452-461.
42. Nordlander M., Have N. Effects of chronic felodipine treatment on renal function and morphology in SHR. Kidney Int. 41:1992;S100-105.